Chronic post-embolic pulmonary hypertension: a new target for medical therapies?},

Marion Delcroix

Source: Eur Respir Rev 2013; 22: 258-264

Journal Issue: September 2013 - 22 (129)

Disease area: Pulmonary vascular diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marion Delcroix. Chronic post-embolic pulmonary hypertension: a new target for medical therapies?},. Eur Respir Rev 2013; 22: 258-264

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Chronic thromboembolic pulmonary hypertension: do we need a new definition? Source: Eur Respir J 2014; 44: 1401-1403 Year: 2014
Thrombo-embolic pulmonary hypertension: which treatment should we choose? / Hypertension pulmonaire thrombo-embolique: quel traitement choisir ? Source: International Congress 2018 – French Programme 2018: Part II Year: 2018
Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow?}, Source: Eur Respir Rev 2013; 22: 217-226 Year: 2013
Emerging anti-inflammatory strategies for COPD}, Source: Eur Respir J 2012; 40: 724-741 Year: 2012
Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options Source: Eur Respir Rev 2009; 18: 24-28 Year: 2009
Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future}, Source: Eur Respir Rev 2013; 22: 281-291 Year: 2013
Different treatment modalities in chronic thromboembolic pulmonary hypertension: how to combine them? Source: International Congress 2017 – Open questions in pulmonary vascular diseases Year: 2017
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era}, Source: Eur Respir J 2012; 40: 881-885 Year: 2012
The effectiveness of anti-inflammatory therapy for chronic obstructive pulmonary disease complicated by ischemic heart disease (new medication - new opportunities) Source: International Congress 2014 – Comorbidities Year: 2014
Learning to pair therapies and the expanding matrix for pulmonary arterial hypertension: is more better? Source: Eur Respir J 2006 Oct 01;28(4):683-686 Year: 2006
Treatment of pulmonary hypertension due to COPD: can we really hope in better? Source: Eur Respir J 2005; 26: Suppl. 49, 562s Year: 2005
Drug-induced pulmonary arterial hypertension: a recent outbreak}, Source: Eur Respir Rev 2013; 22: 244-250 Year: 2013
Chronic thromboembolic pulmonary hypertension Source: Eur Respir Mon 2012; 57: 108-118 Year: 2012
Update on current treatment options of pulmonary hypertension Source: Annual Congress 2006 - Pulmonary hypertension at the crossroads of science and clinical medicine Year: 2006
Interventional treatment of pulmonary hypertension: where are we now? Source: Virtual Congress 2020 – Breathing disorders and cardiovascular diseases Year: 2020
Combination therapy for chronic obstructive pulmonary disease: one size fits all? Source: Eur Respir J 2003 Dec 01;22(6):874-875 Year: 2003
Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready? Source: Eur Respir J 2014; 44: 1404-1407 Year: 2014
Antithrombotics in pulmonary hypertension: more work needed before we turn to newer agents! Source: Eur Respir J 2013; 41: 775-777 Year: 2013
Pulmonary hypertension: new guidelines for therapy Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment Year: 2007